Monoclonal Gammopathy of Undetermined Significance.
Gonsalves WI, Rajkumar SV.
Ann Intern Med. 2022 Dec;175(12):ITC177-ITC192. doi: 10.7326/AITC202212200. Epub 2022 Dec 13.
Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review.
Kaur J, Valisekka SS, Hameed M, Bandi PS, Varma S, Onwughalu CJ, Ibrahim H, Mongia H.
Clin Lymphoma Myeloma Leuk. 2023 May;23(5):e195-e212. doi: 10.1016/j.clml.2023.02.004. Epub 2023 Feb 23.
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M; International Myeloma Working Group.
Leukemia. 2010 Jun;24(6):1121-7. doi: 10.1038/leu.2010.60. Epub 2010 Apr 22.
Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance: A Review.
Liu Y, Parks AL.
JAMA Intern Med. 2025 Apr 1;185(4):450-456. doi: 10.1001/jamainternmed.2024.8124.
Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.
Amaador K, Peeters H, Minnema MC, Nguyen TQ, Dendooven A, Vos JMI, Croockewit AJ, van de Donk NWCJ, Jacobs JFM, Wetzels JFM, Sprangers B, Abrahams AC.
Neth J Med. 2019 Sep;77(7):243-254.
Identifying monoclonal gammopathy of undetermined significance from electronic health records.
Tanenbaum HC, Birmann BM, Bertrand KA, Teras LR, Krishnan AY, Pourhassan H, Goldsmith S, Cannavale K, Wang SS, Chao CR.
Cancer Rep (Hoboken). 2023 Mar;6(3):e1755. doi: 10.1002/cnr2.1755. Epub 2022 Dec 4.
Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.
Seth S, Zanwar S, Vu L, Kapoor P.
Curr Hematol Malig Rep. 2020 Apr;15(2):45-55. doi: 10.1007/s11899-020-00569-2.
Overweight/Obesity and Monoclonal Gammopathy of Undetermined Significance.
Georgakopoulou R, Andrikopoulou A, Sergentanis TN, Fiste O, Zagouri F, Gavriatopoulou M, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA.
Clin Lymphoma Myeloma Leuk. 2021 Jun;21(6):361-367. doi: 10.1016/j.clml.2021.01.008. Epub 2021 Jan 15.
Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
Ho M, Patel A, Goh CY, Moscvin M, Zhang L, Bianchi G.
Leukemia. 2020 Dec;34(12):3111-3125. doi: 10.1038/s41375-020-01051-x. Epub 2020 Oct 12.
Cutaneous manifestations of monoclonal gammopathy.
Claveau JS, Wetter DA, Kumar S.
Blood Cancer J. 2022 Apr 11;12(4):58. doi: 10.1038/s41408-022-00661-1.
